Control at hospital level of infections by methicillin-resistant staphylococci in children.
Identifieur interne : 002B23 ( PubMed/Corpus ); précédent : 002B22; suivant : 002B24Control at hospital level of infections by methicillin-resistant staphylococci in children.
Auteurs : M F Michel ; C C PriemSource :
- The Journal of hygiene [ 0022-1724 ] ; 1971.
English descriptors
- KwdEn :
- Anti-Infective Agents, Local (therapeutic use), Bacteriophage Typing, Child, Preschool, Cross Infection (prevention & control), Gentamicins (therapeutic use), Hexachlorophene (therapeutic use), Humans, Infant, Infant, Newborn, Methicillin (pharmacology), Nose (microbiology), Penicillin Resistance, Staphylococcal Infections (prevention & control).
- MESH :
- chemical , pharmacology : Methicillin.
- chemical , therapeutic use : Anti-Infective Agents, Local, Gentamicins, Hexachlorophene.
- microbiology : Nose.
- prevention & control : Cross Infection, Staphylococcal Infections.
- Bacteriophage Typing, Child, Preschool, Humans, Infant, Infant, Newborn, Penicillin Resistance.
Abstract
Rapid spread of methicillin-resistant staphylococci (MeRS) in a children's hospital is described. Within 4 months of the first isolation MeRS had been isolated from infections in all clinical units. MeRS were also regularly isolated at the out-patient department. Protective isolation of one of the clinical units had no effect on the infection rate by MeRS. The use of antiseptics (Hexachlorophene and chlorhexidine) and gentamicin nose cream in children and staff members in three out of five clinical units resulted in a significant reduction of the prevalence of nose colonization by MeRS in children. In staff members a non-significant reduction of the prevalence of colonization and a significant reduction of the acquisition of MeRS was found. After a few months the infection rate decreased to zero in the units where the measures were introduced. It remained unchanged in the other units. Phage typing of two sets of strains collected at an interval of 6 months showed that the infections were mainly caused by two endemic strains of MeRS. The majority of the infections caused by MeRS was of minor importance. In 16% of the infections a strain was isolated repeatedly and for more than 1 week. After the introduction of antiseptics a relative increase of infections by Gram-negative bacteria was observed. The significance of this phenomenon is discussed.
DOI: 10.1017/s0022172400021707
PubMed: 5285944
Links to Exploration step
pubmed:5285944Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Control at hospital level of infections by methicillin-resistant staphylococci in children.</title><author><name sortKey="Michel, M F" sort="Michel, M F" uniqKey="Michel M" first="M F" last="Michel">M F Michel</name></author><author><name sortKey="Priem, C C" sort="Priem, C C" uniqKey="Priem C" first="C C" last="Priem">C C Priem</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1971">1971</date><idno type="RBID">pubmed:5285944</idno><idno type="pmid">5285944</idno><idno type="doi">10.1017/s0022172400021707</idno><idno type="wicri:Area/PubMed/Corpus">002B23</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B23</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Control at hospital level of infections by methicillin-resistant staphylococci in children.</title><author><name sortKey="Michel, M F" sort="Michel, M F" uniqKey="Michel M" first="M F" last="Michel">M F Michel</name></author><author><name sortKey="Priem, C C" sort="Priem, C C" uniqKey="Priem C" first="C C" last="Priem">C C Priem</name></author></analytic><series><title level="j">The Journal of hygiene</title><idno type="ISSN">0022-1724</idno><imprint><date when="1971" type="published">1971</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Infective Agents, Local (therapeutic use)</term><term>Bacteriophage Typing</term><term>Child, Preschool</term><term>Cross Infection (prevention & control)</term><term>Gentamicins (therapeutic use)</term><term>Hexachlorophene (therapeutic use)</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Methicillin (pharmacology)</term><term>Nose (microbiology)</term><term>Penicillin Resistance</term><term>Staphylococcal Infections (prevention & control)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Methicillin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Infective Agents, Local</term><term>Gentamicins</term><term>Hexachlorophene</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Nose</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cross Infection</term><term>Staphylococcal Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Bacteriophage Typing</term><term>Child, Preschool</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Penicillin Resistance</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Rapid spread of methicillin-resistant staphylococci (MeRS) in a children's hospital is described. Within 4 months of the first isolation MeRS had been isolated from infections in all clinical units. MeRS were also regularly isolated at the out-patient department. Protective isolation of one of the clinical units had no effect on the infection rate by MeRS. The use of antiseptics (Hexachlorophene and chlorhexidine) and gentamicin nose cream in children and staff members in three out of five clinical units resulted in a significant reduction of the prevalence of nose colonization by MeRS in children. In staff members a non-significant reduction of the prevalence of colonization and a significant reduction of the acquisition of MeRS was found. After a few months the infection rate decreased to zero in the units where the measures were introduced. It remained unchanged in the other units. Phage typing of two sets of strains collected at an interval of 6 months showed that the infections were mainly caused by two endemic strains of MeRS. The majority of the infections caused by MeRS was of minor importance. In 16% of the infections a strain was isolated repeatedly and for more than 1 week. After the introduction of antiseptics a relative increase of infections by Gram-negative bacteria was observed. The significance of this phenomenon is discussed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">5285944</PMID><DateCompleted><Year>1971</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1724</ISSN><JournalIssue CitedMedium="Print"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>1971</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of hygiene</Title><ISOAbbreviation>J Hyg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Control at hospital level of infections by methicillin-resistant staphylococci in children.</ArticleTitle><Pagination><MedlinePgn>453-60</MedlinePgn></Pagination><Abstract><AbstractText>Rapid spread of methicillin-resistant staphylococci (MeRS) in a children's hospital is described. Within 4 months of the first isolation MeRS had been isolated from infections in all clinical units. MeRS were also regularly isolated at the out-patient department. Protective isolation of one of the clinical units had no effect on the infection rate by MeRS. The use of antiseptics (Hexachlorophene and chlorhexidine) and gentamicin nose cream in children and staff members in three out of five clinical units resulted in a significant reduction of the prevalence of nose colonization by MeRS in children. In staff members a non-significant reduction of the prevalence of colonization and a significant reduction of the acquisition of MeRS was found. After a few months the infection rate decreased to zero in the units where the measures were introduced. It remained unchanged in the other units. Phage typing of two sets of strains collected at an interval of 6 months showed that the infections were mainly caused by two endemic strains of MeRS. The majority of the infections caused by MeRS was of minor importance. In 16% of the infections a strain was isolated repeatedly and for more than 1 week. After the introduction of antiseptics a relative increase of infections by Gram-negative bacteria was observed. The significance of this phenomenon is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Priem</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hyg (Lond)</MedlineTA><NlmUniqueID>0375374</NlmUniqueID><ISSNLinking>0022-1724</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000891">Anti-Infective Agents, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005839">Gentamicins</NameOfSubstance></Chemical><Chemical><RegistryNumber>IWW5FV6NK2</RegistryNumber><NameOfSubstance UI="D006582">Hexachlorophene</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q91FH1328A</RegistryNumber><NameOfSubstance UI="D008712">Methicillin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000891" MajorTopicYN="N">Anti-Infective Agents, Local</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001434" MajorTopicYN="N">Bacteriophage Typing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005839" MajorTopicYN="N">Gentamicins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006582" MajorTopicYN="N">Hexachlorophene</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008712" MajorTopicYN="N">Methicillin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009666" MajorTopicYN="N">Nose</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010403" MajorTopicYN="Y">Penicillin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1971</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1971</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1971</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">5285944</ArticleId><ArticleId IdType="pmc">PMC2130917</ArticleId><ArticleId IdType="doi">10.1017/s0022172400021707</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rev Fr Etud Clin Biol. 1965 May;10(5):495-506</Citation><ArticleIdList><ArticleId IdType="pubmed">5174147</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1966 Apr 16;1(7442):835-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4159958</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1967 Mar 18;213(5081):1137</Citation><ArticleIdList><ArticleId IdType="pubmed">5182388</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1967 Sep;65(3):381-93</Citation><ArticleIdList><ArticleId IdType="pubmed">5233991</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 1968 Mar 16;1(11):444-6</Citation><ArticleIdList><ArticleId IdType="pubmed">5185252</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1968 Jun 6;278(23):1243-7</Citation><ArticleIdList><ArticleId IdType="pubmed">5647754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1968 Jul 27;2(7561):177-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4173401</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1968 Aug 29;279(9):441-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4232865</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 1968 Dec 28;2(26):1163-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4236529</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott Med J. 1969 Jan;14(1):23-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4885133</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1969 Sep 18;281(12):627-35</Citation><ArticleIdList><ArticleId IdType="pubmed">5194719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1970 Mar 14;225(5237):1074</Citation><ArticleIdList><ArticleId IdType="pubmed">5198089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1970 Apr 18;1(7651):800-4</Citation><ArticleIdList><ArticleId IdType="pubmed">4191434</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1970 Jul 13;213(2):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">5467891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1958 Nov 22;2(7056):1075-80</Citation><ArticleIdList><ArticleId IdType="pubmed">13599487</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pathol. 1961 Jul;14:385-93</Citation><ArticleIdList><ArticleId IdType="pubmed">13686776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1961 Sep 2;2(7201):520-2</Citation><ArticleIdList><ArticleId IdType="pubmed">13757232</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J. 1963 Feb 2;1(5326):308-11</Citation><ArticleIdList><ArticleId IdType="pubmed">13984091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 1964 Apr;87:887-99</Citation><ArticleIdList><ArticleId IdType="pubmed">14137628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1964 May;35:183-90</Citation><ArticleIdList><ArticleId IdType="pubmed">14179667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Inst Pasteur (Paris). 1964 Nov;107:691-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14229537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1965 Mar 13;1(7385):595-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14250094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002B23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:5285944
|texte= Control at hospital level of infections by methicillin-resistant staphylococci in children.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:5285944" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |